New Biotechnology Businesses in Manhattan, NY

Zydus Therapeutics Inc. is a biopharmaceutical company based in Pennington, NJ, focused on developing life-changing therapies. The website highlights their pipeline and dedication to patient care, with contact information matching the LLC's name and industry.

Spore.Bio is a biotechnology company applying AI and photonics to accelerate microbiology testing, particularly in food safety. The company's website (spore.bio) promotes its technology and impact. News articles confirm a $23M Series A funding round.

Argo Biopharma is a biopharmaceutical company established in April 2021, focusing on developing a new generation of siRNA drugs for chronic diseases. It was founded by returnee scientists with experience in siRNA drug development and has entered multi-asset license agreements with Novartis.

The business likely focuses on biosciences research and development, but specific services or products are not detailed in the available information.

LeonaBio is a publicly traded biotechnology company (NASDAQ: LONA) headquartered in Bothell, WA, developing new therapies for patients. The website lists clinical trials and product candidates. The LLC filing in New York likely represents the corporate entity.

AADI Bioscience is a commercial-stage biopharmaceutical company focused on developing therapies for difficult-to-treat diseases, primarily through mTOR inhibition. The company recently rebranded to Whitehawk Therapeutics. The website and press releases confirm its active operations.

Alumis Inc. is a publicly traded biotechnology company developing targeted therapies for immune-mediated diseases. The website emphasizes a precision approach to replace broad immunosuppression, with a pipeline built through a merger with Acelyrin. Contact information includes a South San Francisco phone number and a New Jersey address, consistent with a biopharma firm.

Create Medicines is a biotechnology company based in Cambridge, MA, focused on developing in vivo immune cell programming therapies using RNA and lipid nanoparticle (LNP) delivery for cancer, autoimmunity, and fibrosis. The company's website and news coverage confirm active operations and recent rebranding from Myeloid Therapeutics.

Valorum Biologics develops and commercializes high-value biosimilars for niche markets and serious diseases. The company operates from 555 Madison Avenue, New York, matching the LLC's principal address. The LLC 'Valorum Holdings' likely functions as the parent holding entity for this biotechnology firm.

The LLC's principal address is a corporate office in Manhattan, while the website's phone numbers are based in North Carolina, suggesting a holding or operational separation.

Unicycive Therapeutics is a public biotech company developing therapies for chronic kidney disease, including a phosphate binder for hyperphosphatemia. The website provides detailed information about their pipeline, investors, and corporate communication.

GEDNASA LLC is a biotech company offering AI-powered precision medicine and multi-omics-driven molecular diagnostics.

Arctic Capture is a biotechnology company that uses genetically engineered bacteria and advanced robotics to capture carbon dioxide from the atmosphere.

Remunix, Inc. is a biotechnology company developing novel therapeutics for autoimmune diseases. The website describes its focus on fundamental biology of immune cells. The company's address is in Manhattan, NY.